MEP7809A - Nova primjena docetaksela za liječenje hepatoma - Google Patents

Nova primjena docetaksela za liječenje hepatoma

Info

Publication number
MEP7809A
MEP7809A MEP-78/09A MEP7809A MEP7809A ME P7809 A MEP7809 A ME P7809A ME P7809 A MEP7809 A ME P7809A ME P7809 A MEP7809 A ME P7809A
Authority
ME
Montenegro
Prior art keywords
docetaxel
hepatocellular carcinoma
treating hepatocellular
present
treating
Prior art date
Application number
MEP-78/09A
Other languages
English (en)
Inventor
Chin-Wen Chi
Heng-Liang Lin
Tsung-Yun Liu
Wing-Yiu Lui
Gar-Yang Chau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of MEP7809A publication Critical patent/MEP7809A/bs
Publication of ME00624B publication Critical patent/ME00624B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Ovaj pronalazak se zasniva na nalazu da je docetaksel znatno akti vniji proti v ćelija hepatoćelijskih karcinoma od paklitaksela pri koncentracijama do 1 μM. Prema tome ovaj pronalazak daje primjenu docetaksela ili njegovog hidrata u proizvodnji lijeka za primjenu u liječenju hepatoćelijskog karcinoma.
MEP-2009-78A 1999-08-31 2000-08-29 Nova primjena docetaksela za liječenje hepatoma ME00624B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920548.6A GB9920548D0 (en) 1999-08-31 1999-08-31 Treatment of hepatocellular carcinoma
PCT/EP2000/008782 WO2001015675A2 (en) 1999-08-31 2000-08-29 Use of docetaxel for treating hepatocellular carcinoma

Publications (2)

Publication Number Publication Date
MEP7809A true MEP7809A (bs) 2011-12-20
ME00624B ME00624B (me) 2011-12-20

Family

ID=10860081

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2009-78A ME00624B (me) 1999-08-31 2000-08-29 Nova primjena docetaksela za liječenje hepatoma

Country Status (34)

Country Link
US (2) US20030158249A1 (bs)
EP (1) EP1214061B1 (bs)
JP (1) JP4866522B2 (bs)
KR (1) KR100670416B1 (bs)
CN (1) CN1174748C (bs)
AT (1) ATE269700T1 (bs)
AU (1) AU777583B2 (bs)
BG (1) BG65913B1 (bs)
BR (1) BR0013625A (bs)
CA (1) CA2382294C (bs)
CZ (1) CZ301378B6 (bs)
DE (1) DE60011794T2 (bs)
DK (1) DK1214061T3 (bs)
EA (1) EA004804B1 (bs)
EE (1) EE05124B1 (bs)
ES (1) ES2218223T3 (bs)
GB (1) GB9920548D0 (bs)
HK (1) HK1048944B (bs)
HR (1) HRP20020171A2 (bs)
HU (1) HU228861B1 (bs)
IL (2) IL147489A0 (bs)
ME (1) ME00624B (bs)
MX (1) MXPA02002041A (bs)
NO (1) NO328527B1 (bs)
NZ (1) NZ517604A (bs)
PL (1) PL212612B1 (bs)
PT (1) PT1214061E (bs)
RS (1) RS50148B (bs)
SI (1) SI1214061T1 (bs)
SK (1) SK286378B6 (bs)
TW (1) TW589180B (bs)
UA (1) UA72927C2 (bs)
WO (1) WO2001015675A2 (bs)
ZA (1) ZA200201408B (bs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
WO2005061474A1 (en) * 2003-12-12 2005-07-07 Quiral Química Do Brasil Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use
KR101420445B1 (ko) * 2005-08-31 2014-07-16 아브락시스 바이오사이언스, 엘엘씨 수 난용성 제약학적 약제 및 항균제를 포함하는 조성물
AU2006284657B2 (en) * 2005-08-31 2012-07-19 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US20080081051A1 (en) * 2006-09-28 2008-04-03 Robert Sabin Method of manufacturing anti-tumor and anti-viral compositions
JP2010524919A (ja) * 2007-04-23 2010-07-22 サン、ファーマスーティカル、インダストリーズ、リミテッド 医薬組成物
FR2917088B1 (fr) * 2007-06-08 2009-09-04 Aventis Pharma Sa Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
CA3051495A1 (en) 2010-03-26 2011-09-29 Abraxis Bioscience, Llc Use of nanoparticles comprising a taxane and albumin in the treatment of hepatocellular carcinoma
EA027666B1 (ru) * 2010-05-03 2017-08-31 ТЕИКОКУ ФАРМА ЮСЭй, ИНК. Неводные лекарственные средства в форме проэмульсии на основе таксанов и способы их приготовления и использования
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
US20160250177A1 (en) * 2015-02-17 2016-09-01 Mallinckrodt Llc Modified docetaxel liposome formulations and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
ES2133158T3 (es) * 1993-01-19 1999-09-01 Warner Lambert Co Formulacion ci-981 oral, estable y proceso de preparacion del mismo.
US5846945A (en) * 1993-02-16 1998-12-08 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
FR2718963B1 (fr) * 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle composition pharmaceutique à base de taxoïdes.
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US5968972A (en) 1995-10-26 1999-10-19 Baker Norton Pharmaceuticals, Inc. Method for increasing the oral bioactivity of pharmaceutical agents
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
FR2742751B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
EP0954283B1 (en) * 1996-12-30 2007-03-21 Battelle Memorial Institute Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation
BRPI9810945B8 (pt) * 1997-06-27 2021-05-25 Abraxis Bioscience Inc formulações de agentes farmacológicos, métodos para sua preparação e métodos para uso das mesmas
ATE233104T1 (de) * 1997-09-18 2003-03-15 Janssen Pharmaceutica Nv Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
BR9916536A (pt) * 1998-12-23 2002-01-02 Searle & Co Método para o tratamento ou prevenção de um distúrbio de neoplasia em um mamìfero em necessidade deste tratamento ou prevenção, e, combinação
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
TW200745026A (en) * 2005-12-13 2007-12-16 Teva Pharma Crystal form of atorvastatin hemi-calcium and processes for preparation thereof

Also Published As

Publication number Publication date
EA200200313A1 (ru) 2002-08-29
AU777583B2 (en) 2004-10-21
EP1214061A2 (en) 2002-06-19
IL147489A0 (en) 2002-08-14
NO328527B1 (no) 2010-03-08
NO20020829D0 (no) 2002-02-20
US20080045584A1 (en) 2008-02-21
CZ2002739A3 (cs) 2002-06-12
CZ301378B6 (cs) 2010-02-03
DK1214061T3 (da) 2004-11-01
PL353198A1 (en) 2003-11-03
BG65913B1 (bg) 2010-05-31
HK1048944B (zh) 2005-04-22
SI1214061T1 (en) 2004-12-31
PT1214061E (pt) 2004-09-30
NO20020829L (no) 2002-02-20
ES2218223T3 (es) 2004-11-16
US20030158249A1 (en) 2003-08-21
RS50148B (sr) 2009-05-06
CA2382294A1 (en) 2001-03-08
ZA200201408B (en) 2003-07-30
YU11402A (sh) 2005-07-19
EE05124B1 (et) 2009-02-16
EP1214061B1 (en) 2004-06-23
DE60011794T2 (de) 2005-07-14
KR20020060166A (ko) 2002-07-16
JP4866522B2 (ja) 2012-02-01
WO2001015675A2 (en) 2001-03-08
BG106460A (bg) 2002-09-30
TW589180B (en) 2004-06-01
JP2003508427A (ja) 2003-03-04
KR100670416B1 (ko) 2007-01-17
HUP0203197A3 (en) 2005-01-28
HUP0203197A2 (hu) 2003-01-28
EA004804B1 (ru) 2004-08-26
CN1174748C (zh) 2004-11-10
WO2001015675A3 (en) 2001-09-20
CN1372466A (zh) 2002-10-02
UA72927C2 (uk) 2005-05-16
PL212612B1 (pl) 2012-10-31
GB9920548D0 (en) 1999-11-03
ATE269700T1 (de) 2004-07-15
AU7516800A (en) 2001-03-26
EE200200087A (et) 2003-04-15
HRP20020171A2 (en) 2004-02-29
SK286378B6 (sk) 2008-08-05
CA2382294C (en) 2008-06-03
ME00624B (me) 2011-12-20
HU228861B1 (hu) 2013-06-28
DE60011794D1 (de) 2004-07-29
HK1048944A1 (en) 2003-04-25
MXPA02002041A (es) 2002-08-20
BR0013625A (pt) 2002-05-14
IL147489A (en) 2006-06-11
SK2712002A3 (en) 2002-07-02
NZ517604A (en) 2004-04-30

Similar Documents

Publication Publication Date Title
MEP7809A (bs) Nova primjena docetaksela za liječenje hepatoma
HRP20040059B1 (hr) Tretman infekcije nokta s no
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
ATE430573T1 (de) Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen
PL375621A1 (pl) Kompozycje farmaceutyczne zawierające flawonoidy i mentol
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
BR0308854A (pt) Benzazolas substituìdas e seus usos como inibidoras de quinase raf
MEP36908A (bs) ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
AR035482A1 (es) Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos
NO20034204L (no) Farmasöytiske kombinasjoner til behandling av kreft
EA200300201A1 (ru) Композиция фентанила для интраназального введения
HUP9903906A2 (hu) Kelátképző clioquinol felhasználása Alzheimer-kór kezelésére alkalmas gyógyszerkészítmények előállításánál
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
NO964433L (no) Farmasöytiske preparater på basis av derivater av taxanklassen
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
BR0215336A (pt) Utilização de um composto ou um sal farmaceuticamente aceitável do mesmo, composto, e composição farmacêutica
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE60023321D1 (de) Zusammensetzung gegen Coccidiose
ECSP972332A (es) Derivados de 6-fenilpiridil -2-amina